Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt)-Reference-Cited by-同舟云学术

Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt)

Published:2011-07-28 Issue:14 Volume:54 Page:5154-5164
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tal-Gan Yftah,Hurevich Mattan,Klein Shoshana,Ben-Shimon Avraham,Rosenthal David,Hazan Carina,Shalev Deborah E.,Niv Masha Y.,Levitzki Alexander,Gilon Chaim

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm2003969

Reference68 articles.

1. Targeting the EGFR and the PKB pathway in cancer

2. Toward a PKB Inhibitor: Modification of a Selective PKA Inhibitor by Rational Design

3. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors

4. The selectivity of protein kinase inhibitors: a further update

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The solution structure of macrocyclic glecaprevir and its conformational adaptation mechanism towards antitumor targets;Journal of Molecular Structure;2025-02

2. Harnessing the cyclization strategy for new drug discovery;Acta Pharmaceutica Sinica B;2022-12

3. The current state of backbone cyclic peptidomimetics and their application to drug discovery;Peptide and Peptidomimetic Therapeutics;2022

4. Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis;JACS Au;2021-11-24

5. Engineering “Antimicrobial Peptides” and Other Peptides to Modulate Protein-Protein Interactions in Cancer;Current Topics in Medicinal Chemistry;2020-12-03